​​​​​​​​​South East London Area Prescribing Committee


This page is being updated until the content is moved to the SEL CCG website

The South East London Area Prescribing Committee (APC) was established in 2013 and is a partnership committee which discusses and makes recommendations on medicines issues.

Partner NHS organisations in South East London who are part of the APC are:

Bexley, Bromley, Greenwich, Lambeth, Lewisham and Southwark Clinical Commissioning Groups (CCGs),  Guys and St Thomas Foundation Trust, Kings College Hospital Foundation Trust,  South London and Maudsley Foundation Trust, Oxleas NHS Foundation Trust and Lewisham & Greenwich NHS Trust.

The committee also has representation from local Healthwatch organisations, NHS England London Area Team, and support from Medicines Information Services and the North East London Commissioning Support Unit.

Its aims are;

  • To provide a collective clinical leadership committee to ensure co-operation and consistency of approach to medicines optimisation across South East London
  • To enable all clinicians and commissioners to work together to ensure that patients have safe and consistent access to  medicines with the best outcomes
  • To advise on implementation of best practice around medicines, including National Institute for Health and Care Excellence ( NICE) guidelines and technology appraisals to encourage rapid and consistent implementation
  • To enable local NHS stakeholders and clinicians to exert a population approach to the prioritisation, improvement and quality of healthcare related to medicines.

The Medicines and Pathways Review Group is a working group of the APC which meets monthly to assess new medicines for prescribing within South East London, where these are intended to be prescribed in primary care or commissioned by Clinical Commissioning Groups.  Where primary care or commissioned medicines are subject to a new NICE technology appraisal, the APC will advise on best adoption and implementation in line with NICE. South East London wide treatment pathways and prescribing guidelines are also developed through the Committee and its sub-groups. 

The Local Trusts retain a Joint Formulary Committee which considers new drugs and changes of use of existing drugs which are used only within hospitals and are not subject to any specific commissioning arrangements.

If you are a South East London clinician and you wish to make an application for a new medicine to be considered by the APC please contact your local trust formulary pharmacist or, for primary care applications, your CCG medicines team.

Correspondence to the APC should be directed to:

T: 020 3049 4197

E: lamccg.medicinesoptimisation@nhs.net

1. Emollient Guideline SEL FINAL Oct 2020.pdf
2 Emollients patient information leaflet June 2018.pdf
3. Emollients Patient Template letters.docx
Adult Focal Epilepsy treatment pathway FINAL Oct 2020.pdf
Allergic rhinitis pathway June 2019.pdf
Anal Fissure pathway FINAL May 2018.pdf
Chronic Constipation Guidelines Dec 2017.pdf
COPD guideline SEL updated Dec 2020 FINAL.pdf
Dermatology Guidelines for Primary Care FINAL January 2020.pdf
Dermatology Specials fact sheet - Beclometasone diproprionate Dec 2017.pdf
Dermatology Specials fact sheet - clobetasol propionate Dec 2017.pdf
Dermatology Specials fact sheet - Lactic acid in Diprobase cream Dec 2017.pdf
Dermatology Specials fact sheet - Monobenzone in cetomacrogol Dec 2017.pdf
Erectile dysfunction treatment guidance Dec 2020 FINAL.pdf
Gastroparesis treatment pathway Adults FINAL Oct 2020.pdf
Glaucoma - Ocular Hypertension treatment pathway Jan 2018.pdf
Guidance HPV vaccine anogenital warts Dec 2019 FINAL.pdf
Hyperhidrosis pathway Nov 2018.pdf
Hypersalivation management options SEPT 2019 FINAL.pdf
IBD Pathway Monitoring Framework 2016.pdf
IBD pathways with Fe deficiency pathway June 2019 FINAL.pdf
Immune Thrombocytopenia (ITP) adult Pathway FINAL July 2020.pdf
Intravitreal pathway April 2018.pdf
Irritable Bowel Syndrome Pathway (adults) FINAL July 2020.pdf
Leaflet - DELMOSART - for methylphenidate MR switch FINAL.pdf
Leaflet - XENIDATE for methylphenidate MR switch  FINAL.pdf
Lidocaine Plasters Deprescribing Guide Feb 2019.pdf
Management of Adult Non-Cancer Chronic Pain March 2019.pdf
Management of cows milk protein allergy in Primary Care Apr 19.pdf
Management of Motor Symptoms in Parkinson's Disease July 2018.pdf
Melatonin paediatric prescribing guidance FINAL OCT 2020.pdf
Neuropathic Pain (Adults) guidance SEL Oct 2019 FINAL.pdf
Neuropathic pain (refractory) AED meds info ADULTS July 2020 FINAL.pdf
NICE and SPS Clinical guidance  Covid-19 FINAL.pdf
OAB adults pathway Feb 2020.pdf
Oral medicine treatments (off label) GUIDE Jan 19.pdf
Papulopustular Rosacea treatment pathway March 2019.pdf
Psoriasis Biologic Pathway ADULTS July 2020 FINAL.pdf
Psoriasis Pathway Outcomes Monitoring Framework July 2020 FINAL.pdf
Reconciling hospital only medicines in primary care FINAL Oct 2020.docx
Reconciling hospital only medicines in primary care FINAL Oct 2020.pdf
Restless Legs Syndrome GP Fact Sheet May 2017.pdf
Restless Legs Syndrome Patient leaflets.pdf
Restless Legs Syndrome Treatment Pathway update Feb 2020 FINAL.PDF
Rheumatoid Atrhritis treatment pathway FINAL Jan 2021.pdf
Rheumatology PathwayMonitoring Framework Dec 2019 FINAL.pdf
SEL Asthma Guideline Apr 2019.pdf
Seronegative spondyloarthropathy pathway Jan 2021 FINAL.pdf
SLEEP Cataplexy with narcolepsy pathway Aug 2018.pdf
SLEEP GP information on Sleep Hygiene.pdf
SLEEP Narcolepsy GP Factsheet Aug 2018.pdf
SLEEP Narcolepsy pathway Aug 2018.pdf
SLEEP Non-REM Medicines Information Aug 2018.pdf
SLEEP Non-REM parasomnia pathway Aug 2018.pdf
SLEEP Non-REM parasomnias GP fact sheet Aug 2018.pdf
SLEEP RBD behaviour GP fact sheet Aug 2018.pdf
SLEEP RBD medicines information Aug 2018.pdf
SLEEP REM Behaviour Disorder pathway Aug 18.pdf
Stoma Care REVIEW letter  template FINAL.docx
Stoma Care TRANSFER OF CARE letter template FINAL.docx
STOMP and STAMP Guidance SEL FINAL July 2020.pdf
Testosterone gel or sachets for menopause leaflet FINAL June 2019.pdf
Ulipristal Acetate (Esyma) interim statement Feb 18.pdf
Urticaria Treatment Pathway FINAL Dec 2018.pdf
Valproate GP actions flyer September 2018.pdf
Vitamin D guideline ADULTS FINAL July 2020.pdf
Vitamin D Guideline CHILDREN FINAL July 2020.pdf
Vitamin D Patient Information Leaflet FINAL July 2020.pdf